Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Massachusetts Rx

Executive Summary

Massachusetts may suspend its Rx drug insurance program Prescription Advantage April 1 if its waiver request is not approved by the Centers for Medicare & Medicaid Services. The waiver would reimburse the state for half the costs of the $100 mil.-a-year drug program; 80,000 seniors are enrolled (1"The Pink Sheet" April 9, 2001, p. 17). Massachusetts plans to develop a new senior drug discount program by the end of March...

You may also be interested in...

Massachusetts To Assume Risk In Rx Insurance Contract With AdvancePCS

Massachusetts will serve as the risk-bearing entity in its contract with the pharmacy benefit manager AdvancePCS for the state's prescription drug insurance program.

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts